Transformer-based molecular optimization beyond matched molecular pairs

被引:35
作者
He, Jiazhen [1 ]
Nittinger, Eva [2 ]
Tyrchan, Christian [2 ]
Czechtizky, Werngard [2 ]
Patronov, Atanas [1 ]
Bjerrum, Esben Jannik [1 ]
Engkvist, Ola [1 ,3 ]
机构
[1] AstraZeneca, Mol AI, R&D, Discovery Sci, Gothenburg, Sweden
[2] AstraZeneca, BioPharmaceut R&D, Resp & Immunol R&I, Med Chem Res & Early Dev, Gothenburg, Sweden
[3] Chalmers Univ Technol, Dept Comp Sci & Engn, Gothenburg, Sweden
关键词
Molecular optimization; Matched molecular pairs; Transformer; Tanimoto similarity; Scaffold; ADMET; GENERATION;
D O I
10.1186/s13321-022-00599-3
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Molecular optimization aims to improve the drug profile of a starting molecule. It is a fundamental problem in drug discovery but challenging due to (i) the requirement of simultaneous optimization of multiple properties and (ii) the large chemical space to explore. Recently, deep learning methods have been proposed to solve this task by mimicking the chemist's intuition in terms of matched molecular pairs (MMPs). Although MMPs is a widely used strategy by medicinal chemists, it offers limited capability in terms of exploring the space of structural modifications, therefore does not cover the complete space of solutions. Often more general transformations beyond the nature of MMPs are feasible and/or necessary, e.g. simultaneous modifications of the starting molecule at different places including the core scaffold. This study aims to provide a general methodology that offers more general structural modifications beyond MMPs. In particular, the same Transformer architecture is trained on different datasets. These datasets consist of a set of molecular pairs which reflect different types of transformations. Beyond MMP transformation, datasets reflecting general structural changes are constructed from ChEMBL based on two approaches: Tanimoto similarity (allows for multiple modifications) and scaffold matching (allows for multiple modifications but keep the scaffold constant) respectively. We investigate how the model behavior can be altered by tailoring the dataset while using the same model architecture. Our results show that the models trained on differently prepared datasets transform a given starting molecule in a way that it reflects the nature of the dataset used for training the model. These models could complement each other and unlock the capability for the chemists to pursue different options for improving a starting molecule.
引用
收藏
页数:14
相关论文
共 38 条
  • [11] Generative Recurrent Networks for De Novo Drug Design
    Gupta, Anvita
    Mueller, Alex T.
    Huisman, Berend J. H.
    Fuchs, Jens A.
    Schneider, Petra
    Schneider, Gisbert
    [J]. MOLECULAR INFORMATICS, 2018, 37 (1-2)
  • [12] He J, 2021, ICLR 2021 WORKSH MAC
  • [13] Molecular optimization by capturing chemist's intuition using deep neural networks
    He, Jiazhen
    You, Huifang
    Sandstrom, Emil
    Nittinger, Eva
    Bjerrum, Esben Jannik
    Tyrchan, Christian
    Czechtizky, Werngard
    Engkvist, Ola
    [J]. JOURNAL OF CHEMINFORMATICS, 2021, 13 (01)
  • [14] Jin W, 2019, 1907 ARXIV
  • [15] Jin W., 2018, INT C LEARN REPR
  • [16] Jin WG, 2020, PR MACH LEARN RES, V119
  • [17] Jin WG, 2018, PR MACH LEARN RES, V80
  • [18] druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico
    Kadurin, Artur
    Nikolenko, Sergey
    Khrabrov, Kuzma
    Aliper, Alex
    Zhavoronkov, Alex
    [J]. MOLECULAR PHARMACEUTICS, 2017, 14 (09) : 3098 - 3104
  • [19] Kenny PW, 2005, METH PRIN MED CHEM, V22, P271, DOI 10.1002/3527603743.ch11
  • [20] Direct steering of de novo molecular generation with descriptor conditional recurrent neural networks
    Kotsias, Panagiotis-Christos
    Arus-Pous, Josep
    Chen, Hongming
    Engkvist, Ola
    Tyrchan, Christian
    Bjerrum, Esben Jannik
    [J]. NATURE MACHINE INTELLIGENCE, 2020, 2 (05) : 254 - +